| Literature DB >> 34026108 |
Ata Garajei1,2, Ali A Kheradmand2,3, Seyed Roohollah Miri2,4, Azadeh Emami5.
Abstract
PURPOSE: To assess the availability, success rate and complications of microvascular iliac crest free flap for reconstruction of mandibular segmental defects.Entities:
Keywords: Flap; Iliac crest; Mandibular; Reconstruction; Segmental
Year: 2021 PMID: 34026108 PMCID: PMC8121997 DOI: 10.1016/j.amsu.2021.102354
Source DB: PubMed Journal: Ann Med Surg (Lond) ISSN: 2049-0801
Fig. 1A. Preoperational photograph of a 40 y/o male case presenting Ameloblastoma of left side of mandible. B. Preoperational panoramic radiograph showing the extension of tumor from angle to the ramus and coronoid process. C. Diagnostic CT-Scan showing the perforation of buccal and lingual plates. D. Intraoperative photograph after tumor resection and reconstruction plate fixation. E. The iliac crest free flap with vascular pedicle was harvested. F. The graft was inserted into the defect, fixed to the existing reconstruction plate and the pedicle was anastomosed to the recipient artery and vein. Note the contour of the graft, which is similar to that of the defect. G. Immediate post operational panoramic radiograph. H. Twelve month follow up panoramic radiograph. I. Fifty six month follow up panoramic radiograph. G. Five year follow up photograph showing excellent contour and symmetry. K. Preoperational Cone-Beam CT scan of a 24 y/o case presenting Ameloblastoma of left side of mandibular body.
Fig. 2A. Intraoperative photograph of the donor site. B. Intraoperative photograph of the iliac crest free flap with vascular pedicle. C. Intraoperative photograph after tumor resection, reconstruction plate fixation and graft fixation to the plate. D. Immediate post operational panoramic radiograph. E. Thirty eight months follow up radiograph. F. Thirty eight months follow up- Clinical view.
Data of cases with mandibular defects reconstructed using iliac free flap.
| Patient No. | Tumor | Age | Sex | Extension To Soft Tissue | Length Of Defect ( | Type Of Reconstruction | Follow Up (Months) | Postop Complications |
|---|---|---|---|---|---|---|---|---|
| 1 | Ameloblastoma | 24 | Female | No | 7 | Primary | 40 | No |
| 2 | Ameloblastoma | 27 | Female | No | 8 | Primary | 39 | No |
| 3 | Ameloblastoma | 40 | Male | No | 14 | Primary | 56 | No |
| 4 | Ameloblastoma | 32 | Male | No | 14 | Primary | 55 | No |
| 5 | Ameloblastoma | 26 | Female | Yes* | 8 | Secondary | 46 | No |
| 6 | Ameloblastoma | 24 | Female | No | 10 | Primary | 38 | No |
| 7 | Ameloblastoma | 14 | Male | No | 15 | Primary | 32 | No |
| 8 | Ameloblastoma | 22 | Male | No | 6 | Primary | 60 | No |
| 9 | Ameloblastoma | 28 | Female | No | 8 | Primary | 13 | No |
| 10 | Ameloblastoma | 30 | Female | No | 12 | Primary | 31 | No |
| 11 | Central Giant Cell Granuloma | 34 | Female | No | 12 | Primary | 55 | No |
| 12 | Central Giant Cell Granuloma | 27 | Female | No | 10 | Primary | 36 | No |
| 13 | Central Giant Cell Granuloma | 25 | Female | No | 10 | Primary | 28 | No |
| 14 | Central Giant Cell Granuloma | 28 | Male | No | 12 | Secondary | 52 | No |
| 15 | Central Giant Cell Granuloma | 27 | Male | No | 14 | Primary | 41 | No |
| 16 | Central Giant Cell Granuloma | 35 | Female | Yes* | 10 | Secondary | 60 | Yes* |
| 17 | Desmoplastic Fibroma | 18 | Female | No | 4 | Primary | 24 | No |
| 18 | Desmoplastic Fibroma | 18 | Female | No | 6 | Primary | 12 | No |
| 19 | Hemangioma | 24 | Female | No | 6 | Primary | 48 | No |
| 20 | Hemangioma | 28 | Male | No | 10 | Primary | 50 | No |
| 21 | Hemangioma | 28 | Female | No | 9 | Primary | 42 | No |
| 22 | Hemangioma | 24 | Female | No | 8 | Primary | 17 | No |
| 23 | Odontogenic Myxoma | 32 | Male | No | 6 | Primary | 60 | No |
| 24 | Odontogenic Myxoma | 31 | Male | No | 8 | Primary | 50 | No |
| 25 | Osteogenic Sarcoma | 18 | Male | No | 8 | Secondary | 23 | Yes* |
| 26 | Osteogenic Sarcoma | 32 | Male | No | 8 | Secondary | 40 | Yes* |
| 27 | Osteogenic Sarcoma | 20 | Female | No | 6 | Secondary | 23 | Yes* |
| 28 | Osteogenic Sarcoma | 22 | Female | No | 6 | Secondary | 23 | Yes* |
| 29 | Osteogenic Sarcoma | 30 | Male | No | 8 | Primary | 32 | Yes* |
| 30 | SCC | 40 | Male | Yes* | 10 | Secondary | 26 | Yes* |
Baseline Participants’ characteristics by post-surgical complication group.
| Characteristic | N (%) | With post-surgery complication | Without post-surgery complication | P. Value |
|---|---|---|---|---|
| No. (%) | 30 (100%) | 7 (23.3) | 23 (76.7) | |
| Age, Mean (S.E Mean), Year | 28.14 (3.14) | 9.39 (1.18) | 0 .656 | |
| Tumor length, Mean (S.E Mean), | 8 (0 .62) | 9.39 (3) | 0.216 | |
| Follow up duration, Mean (S.E. Mean), Month | 32.43 (5.18) | 40.22 (5.6) | .435 | |
| Tumor type | ||||
| Ameloblastoma | 10 (33.3%) | 0 | 10 | 0.00* |
| Central Giant Cell Granuloma | 6 (20) | 2 | 4 | |
| Osteogenic Sarcoma | 5 (16.7) | 5 | 0 | |
| Hemangioma | 4 (13.3) | 0 | 4 | |
| Desmoplastic Fibroma | 2 (6.7) | 0 | 2 | |
| Odontogenic Myxoma | 2 (6.7) | 0 | 2 | |
| Squamous Cell Carcinoma | 1 (3.3) | 1 | 0 | |
| Tumor Location | ||||
| Body of mandible | 12 (40) | 2 | 10 | 0.436 |
| Ramus of mandible | 11 (36.7) | 4 | 7 | |
| Body and ramus of mandible | 7 (23.3) | 1 | 6 | |
| Reconstruction | 0.003* | |||
| Primary | 23 | 2 | 21 | |
| Secondary | 7 | 5 | 2 |
Baseline Participants characteristics by post-surgical complication Group.
| Major complications | N | Minor complications | N |
|---|---|---|---|
| Hematoma | 1 | Hematoma | 2 |
| Total necrosis | 1 | Infection | 2 |
| Fistula | 1 | Partial necrosis | 0 |
| Venous thrombosis | 1 | Fistula | 0 |
| Arterial thrombosis | 0 | Dehiscence | 0 |
| Partial necrosis | 0 | ||
| Wrong positioning of flap | 0 | ||
| Plate exposure | 0 | ||
| Infection | 0 | ||
| Dehiscence | 0 | ||
| Hemorrhage | 0 | ||
| Total | 4 | Total | 4 |